Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics

GENEVA, SWITZERLAND - EQS Newswire - 15 December 2025 - MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company) announced today the completion of its business combination with NeuroX Group SA (NeuroX), a commercial-stage company delivering evidence-based, precision digital treatments for neurological diseases.

The newly combined entity now operates under the name MindMaze Therapeutics Holding SA.

The closing follows the signing of a definitive business combination agreement in October 2025 and subsequent shareholder approval at the Company's extraordinary general meeting in November. The transaction establishes a fully integrated company with a first-of-its-kind ecosystem, uniting precision digital neurotherapeutics, pharmacological treatments, cutting-edge devices, data, and an AI-powered platform, positioned to redefine neurological care and change patient lives.

"Neurological diseases are one of the leading causes of disability globally," said Olaf Blanke (MD), member of the Board of Directors, Professor of Neuroscience and Cognitive Neuroprosthetics at the Swiss Federal Institute of Technology (EPFL) and Adjunct Professor at the Department of Clinical Neurosciences at the University Hospital of Geneva. "The situation is worsening due to aging populations, with 1 in 6 people expected to develop a neurological disease, making the need for effective, scalable solutions more urgent than ever. While neuro-rehabilitation requires intensive, repetitive training for functional recovery, traditional healthcare systems often fail to deliver adequate therapy, leaving millions of patients without optimal treatment. MindMaze Therapeutics seeks to address this gap by providing clinically proven neurotherapeutics to support their recovery journey, from hospital to rehab center to their home."

"Today begins a new chapter for MindMaze Therapeutics," commented Walid Hanna, Chairman of the Board of Directors of MindMaze Therapeutics. "The company is founded on clinically validated innovation, and driven by a mission to transform neurological care, addressing a critical and persistent gap in motor and cognition restorations in neurological conditions. We are now focused on advancing our precision neurotherapeutics platform to deliver impact at scale. Relief's complementary capabilities and biopharmaceutical assets strengthen our growth strategy, supporting both drug-digital integration and expanding development opportunities."

MindMaze Therapeutics acquired NeuroX through a share exchange in which all outstanding shares of NeuroX were contributed by its former shareholders in exchange for 140,000,000 newly issued ordinary shares of the Company. These new shares will be admitted to trading and listing on the SIX Swiss Exchange today, in accordance with the approved prospectus and applicable regulations. Effective immediately, all listed ordinary shares of the Company will trade under the updated ticker symbol MMTX. Following the transaction, the total number of outstanding shares amounts to 152,602,044, excluding treasury shares.

DISCLAIMER
This press release contains forward-looking statements, which may be identified by words such as "believe," "assume," "expect," "intend," "may," "could," "will," or similar expressions. These statements are based on current plans and assumptions and are subject to risks and uncertainties that could cause actual results, financial condition, performance, or achievements to differ materially from those expressed or implied. Such factors include, among others, business, economic, financial, regulatory, and competitive factors, as well as the Company's ability to execute its strategy and secure sufficient resources to support its operations. This communication is provided as of the date hereof, and MindMaze Therapeutics undertakes no obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

Additional features:
File: Ad hoc release_MindMaze_Closing Business Combination

The issuer is solely responsible for the content of this announcement.

ABOUT MINDMAZE THERAPEUTICS

MindMaze Therapeutics is a Swiss-based, commercial-stage company formed in December 2025 through the business combination of RELIEF THERAPEUTICS Holding SA (Relief) and NeuroX Group SA. The Company develops and commercializes first-of-its-kind digital treatments for neurological diseases and brain disorders. Built on an advanced brain technology platform integrating software, sensors, and telehealth, its solutions are deployed globally across clinics and home settings. MindMaze Therapeutics' clinically validated neurotherapeutics have demonstrated significant medico-economic outcomes across conditions such as stroke, Parkinson's disease, and at-risk aging. The Company continues to expand its R&D pipeline into adjacent neurological indications, including multiple sclerosis, spinal cord injury, traumatic brain injury, and Alzheimer's disease.

The Company also manages Relief's preexisting portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.

MindMaze Therapeutics is listed on the SIX Swiss Exchange under the ticker and quoted in the U.S. on OTCQB under and .

For more information, visit .


News from Asia

The Hoffman Agency Taps Darren Burns as Asia Pacific President

Appointment builds on the independent consultancy's global ambitionsSILICON VALLEY, USA – Media OutReach Newswire – 17 November 2026 – The Hoffman Agency, an independent global communications cons...

KFC Thailand Breaks Creative Boundaries in 2026 with Bold Campaigns and Its First-Ever Original Manga "Dumb Luck"

Turning Cultural Insights, Pop Culture and Everyday Moments into Unexpected and Unforgettable Brand ExperiencesBANGKOK, THAILAND – Media OutReach Newswire – 17 November 2026 – KFC Thailand has bee...

From Black Friday to Christmas: Garvee Unveils a Holiday Gift Guide for the Year-End Shopping Season

ONTARIO, CANADA – Media OutReach Newswire – 17 November 2026 – With Black Friday, Cyber Monday and Christmas just around the corner, it's time to start thinking about gifts for family, friends and...

CHAGEE Grows to Eight Asia Pacific Markets with Brunei Entry; Unveils New Rooted in Tea Store Design

In the new design, tea is not just what CHAGEE serves, but what shapes the spaceSINGAPORE – Media OutReach Newswire – 17 November 2026 – CHAGEE is growing its family in Asia Pacific, opening its f...

Century-Old Guizhou Time-Honored Brand "Laishigang Sauce-Aroma Baijiu" Establishes Foothold in Hong Kong to Launch Southeast Asian and International Expansion Strategy

HONG KONG SAR – Media OutReach Newswire – 17 November 2026 – Guizhou Laishigang Liquor Co., Ltd. ("Laishigang Liquor"), a fifth-generation, century-old sauce-aroma baijiu producer certified as a ...

THE WORLD ENDS 2026 Connects Asia’s Creative and Design Networks to Unlock New Business Opportunities

International design platform brings together creative talent, industry partners and regional business networks, targeting 200 buyer–seller connections to foster business collaboration and cross-bo...

Ayara Kamala Reveals a Refreshed Vision for Wellness in Phuket

BANGKOK, THAILAND – Media OutReach Newswire – 17 November 2026 - Ayara Kamala Resort & Spa, an intimate haven nestled along Phuket's prestigious Kamala coastline, has officially unveiled its r...

China-Indonesia Cultural Industry Exchange Symposium Held in Jakarta

JAKARTA, INDONESIA – Media OutReach Newswire – 17 November 2026 – On the afternoon of November 13, the China-Indonesia Cultural Industry Exchange Symposium, co-hosted by the China Intercontinental...

Disney and Visa Announce Multi-Year Strategic Alliance Across Asia Pacific

The alliance spans Disney-branded card programmes, cardholder benefits and joint marketing initiatives across the regionHONG KONG SAR – Media OutReach Newswire – 17 November 2026 – The Walt Disney...

Galaxy Resort Presents: "Plácido Domingo & José Carreras: The Legends United Opera Gala"

Greater China and Macau's Only Performance Galaxy Rewards select members can enjoy privileged priority booking from 10 December 2026.Tickets go on public sale from 14 December 2026 CaptionMACAU SAR...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...

Permanent $20,000 Instant Asset Write-Off Gives Small Businesses Greater Planning Certainty

The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...